Inventor · disambiguated record
Henriette Gourdeau
Also filed as: GOURDEAU HENRIETTE
5 granted patents·5 pending applications·42 citations·filing 2000–2009
78Inventor score
Top patents by PatentIndex Score
10 records- 0186US6747036B2Methods of treating leukemiaIAF BIOCHEM INT·Filed 2002·Granted Jun 8, 2004·22 cites·41 claims
- 0284US7358241B2Compositions and methods comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditionsTHALLION PHARMACEUTICALS INC·Filed 2005·Granted Apr 15, 2008·5 cites·21 claims
- 0380US6630480B1Methods of treating leukemiaIAF BIOCHEM INT·Filed 2000·Granted Oct 7, 2003·11 cites·36 claims
- 0469US7763604B2Methods for administration of a farnesyl dibenzodiazepinoneTHALLION PHARMA CEUTICALS INC·Filed 2006·Granted Jul 27, 2010·4 cites·48 claims
- 0560US2004192654A1Methods of treating leukemiaIAF BIOCHEM INT·Filed 2004·Application pending·0 cites
- 0657US2011028458A1Inhibition of cell migration by a farnesylated dibenzodiazepinoneTHALLION PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0751US7968595B2Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereofCYTOVIA INC·Filed 2007·Granted Jun 28, 2011·0 cites·36 claims
- 0849US2009170837A1Methods for treating ras driven cancer in a subjectTHALLION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0949US2004248915A1Method for administration of troxacitabineFiled 2004·Application pending·0 cites
- 1046US2009062255A1Tumor-targeting evaluation methodology and compounds related theretoTHALLION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →